Condition

Non-Resectable Pancreas Carcinoma clinical trials and research

• 2Clinical trials
• 2Countries

All recruiting trials (2)

• First-line sequential AG and mFOLFOX with serplulimab and bevacizumab versus AG alone for advanced pancreatic cancer

  This trial will test whether adding serplulimab and bevacizumab to sequential AG and mFOLFOX chemotherapy helps people with untreated advanced pancreatic cancer live longer than standard AG chemotherapy alone.

  Recruiting Phase 3 Zhejiang Cancer Hospital · Hangzhou, Zhejiang · NCT07235930

• Comparing Gemcitabine and Reduced-dose Combination Chemotherapy for Non-resectable Pancreatic Cancer

  This study is testing whether full-dose Gemcitabine or a lower-dose combination of Gemcitabine and Nab-Paclitaxel works better and is safer for older or frail patients with pancreatic cancer that can't be surgically removed.

  Recruiting Phase 2 Aalborg University Hospital · Aalborg · NCT05841420

Related topics

Quick answers

How many Non-Resectable Pancreas Carcinoma clinical trials are recruiting right now?

2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 2 countries. The most sites are in Denmark (1 trial), China (1 trial). Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 2: 1, Phase 3: 1. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →